课题基金 / 基金详情

Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)

Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除；
批准号：
485524
负责人：
Swardfager Walter L
金额：
$1.46万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=485524&lang=en
关键词：
Aging Cerebral Small Vessels Coronary Artery Disease Diabetes Inflammation Physical Activity

项目摘要

项目成果

Swardfager Walter L的其他基金

相似基金

相关文献

中文摘要
翻译
随着年龄的增长，患痴呆症的风险会增加，特别是在那些患有炎症性疾病的人，如冠状动脉疾病和2型糖尿病。这些情况可能会导致大脑中的小血管疾病，从而导致糖尿病
英文摘要
As people age, the risk of developing dementia increases, especially in those with inflammatory conditions like coronary artery disease and type 2 diabetes mellitus. These conditions can lead to small vessel disease in the brain, which contributes to cogn
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training (PRIMiNG-AT)
Canada Research Chairs - Tier 2
  • 批准号：
    441848
  • 项目类别：
  • 资助金额：
    $43.71万
  • 财政年份：
    2020
  • 负责人：
    Swardfager Walter L
  • 依托单位：
    University of Toronto
Neurocognitive effects of osteocalcin in type 2 diabetes
Relationships between subcortical ischemic vasculopathy, cerebral atrophy and cognitive performance
海外基金